CVD risk factors are related to plasma fibrin clot properties independent of total and or γ’ fibrinogen concentration
Abstract Introduction Cardiovascular disease (CVD) risk factors are associated with total fibrinogen concentration and/or altered clot structure. It is however, unclear whether such associations with clot structure are ascribed to fibrinogen concentration or other independent mechanisms. We aimed to...
Gespeichert in:
Veröffentlicht in: | Thrombosis research 2014-11, Vol.134 (5), p.963-969 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 969 |
---|---|
container_issue | 5 |
container_start_page | 963 |
container_title | Thrombosis research |
container_volume | 134 |
creator | Kotzé, Retha C.M Ariëns, Robert A.S de Lange, Zelda Pieters, Marlien |
description | Abstract Introduction Cardiovascular disease (CVD) risk factors are associated with total fibrinogen concentration and/or altered clot structure. It is however, unclear whether such associations with clot structure are ascribed to fibrinogen concentration or other independent mechanisms. We aimed to determine whether CVD risk factors associated with increased total and/or γ’ fibrinogen concentration, were also associated with altered fibrin clot properties and secondly whether such associations were due to the fibrinogen concentration or through independent associations. Materials and methods In a plasma setting CVD risk factors (including total and γ’ fibrinogen concentration) were cross-sectionally analysed in 2010 apparently healthy black South African participants. Kinetics of clot formation (lag time, slope and maximum absorbance) as well as clot lysis times were calculated from turbidity curves. Results Of the measured CVD risk factors age, metabolic syndrome, C-reactive protein (CRP), high density lipoprotein (HDL)-cholesterol and homocysteine were significantly associated with altered fibrin clot properties after adjustment for total and or γ’ fibrinogen concentration. Aging was associated with thicker fibres (p = 0.004) while both metabolic syndrome and low HDL-cholesterol levels were associated with lower rates of lateral aggregation (slope), (p = 0.0004 and p = 0.0009), and the formation of thinner fibres (p = 0.007 and p = 0.0004). Elevated CRP was associated with increased rates of lateral aggregation (p = 0.002) and consequently thicker fibres (p < 0.0001). Hyperhomocysteinemia was associated with increased rates of lateral aggregation (p = 0.0007) without affecting fibre thickness. Conclusion Final clot structure may contribute to increased CVD risk in vivo through associations with other CVD risk factors independent from total or γ’ fibrinogen concentration. |
doi_str_mv | 10.1016/j.thromres.2014.08.018 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1629969896</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S004938481400454X</els_id><sourcerecordid>1629969896</sourcerecordid><originalsourceid>FETCH-LOGICAL-c423t-5385db5194612555acc5d303757f747687ff3f0a9f6c2f3ba4dce6dd79e7c2703</originalsourceid><addsrcrecordid>eNqFkTuOFDEQhi0EYoeFK6wckkzjZ7udINDwlFYi4CEyy2OXwbPd7cb2IDbjGpyDe3AIToJHM0tAQmI7-P6q8lcIXVDSUUL7R7uufs5pylA6RqjoyNAROtxCKzoovWZCsdtoRYjQaz6I4QzdK2VHCFVUy7vojElGuSJ6hb5tPjzDOZYrHKyrKRdsM-AMo63gcU14GW2ZLA5xm-OM3ZgqXnJaINcIBcfZwwLtmCtOofHVjtjOHqeMf_38_f3HKZg-QQun2TUw2xrTfB_dCXYs8OB0n6P3L56_27xaX755-Xrz9HLtBON1Lfkg_VZSLXrKpJTWOek54UqqoITqBxUCD8Tq0DsW-NYK76D3XmlQjinCz9HDY9029Zc9lGqmWByMo50h7YuhPdO614PuG9ofUZdTKRmCWXKcbL42lJiDdbMzN9bNwbohg2nWW_Di1GO_ncD_jd1obsCTIwDtp18jZFNchGbDxwyuGp_i_3s8_qeEG-McnR2v4BrKLu3z3DwaagozxLw97P6weiraS4qP_A9o-K91</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1629969896</pqid></control><display><type>article</type><title>CVD risk factors are related to plasma fibrin clot properties independent of total and or γ’ fibrinogen concentration</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Kotzé, Retha C.M ; Ariëns, Robert A.S ; de Lange, Zelda ; Pieters, Marlien</creator><creatorcontrib>Kotzé, Retha C.M ; Ariëns, Robert A.S ; de Lange, Zelda ; Pieters, Marlien</creatorcontrib><description>Abstract Introduction Cardiovascular disease (CVD) risk factors are associated with total fibrinogen concentration and/or altered clot structure. It is however, unclear whether such associations with clot structure are ascribed to fibrinogen concentration or other independent mechanisms. We aimed to determine whether CVD risk factors associated with increased total and/or γ’ fibrinogen concentration, were also associated with altered fibrin clot properties and secondly whether such associations were due to the fibrinogen concentration or through independent associations. Materials and methods In a plasma setting CVD risk factors (including total and γ’ fibrinogen concentration) were cross-sectionally analysed in 2010 apparently healthy black South African participants. Kinetics of clot formation (lag time, slope and maximum absorbance) as well as clot lysis times were calculated from turbidity curves. Results Of the measured CVD risk factors age, metabolic syndrome, C-reactive protein (CRP), high density lipoprotein (HDL)-cholesterol and homocysteine were significantly associated with altered fibrin clot properties after adjustment for total and or γ’ fibrinogen concentration. Aging was associated with thicker fibres (p = 0.004) while both metabolic syndrome and low HDL-cholesterol levels were associated with lower rates of lateral aggregation (slope), (p = 0.0004 and p = 0.0009), and the formation of thinner fibres (p = 0.007 and p = 0.0004). Elevated CRP was associated with increased rates of lateral aggregation (p = 0.002) and consequently thicker fibres (p < 0.0001). Hyperhomocysteinemia was associated with increased rates of lateral aggregation (p = 0.0007) without affecting fibre thickness. Conclusion Final clot structure may contribute to increased CVD risk in vivo through associations with other CVD risk factors independent from total or γ’ fibrinogen concentration.</description><identifier>ISSN: 0049-3848</identifier><identifier>EISSN: 1879-2472</identifier><identifier>DOI: 10.1016/j.thromres.2014.08.018</identifier><identifier>PMID: 25213709</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Adult ; Blood Coagulation ; Cardiovascular Diseases - blood ; Cardiovascular Diseases - etiology ; Cardiovascular Diseases - metabolism ; CVD risk factors ; Female ; Fibrin - analysis ; Fibrin - metabolism ; Fibrin Clot Lysis Time ; Fibrin clot structure ; Fibrinogen ; Fibrinogens, Abnormal - analysis ; Fibrinolysis ; Hematology, Oncology and Palliative Medicine ; Humans ; Male ; Middle Aged ; Plasma ; Risk Factors</subject><ispartof>Thrombosis research, 2014-11, Vol.134 (5), p.963-969</ispartof><rights>Elsevier Ltd</rights><rights>2014 Elsevier Ltd</rights><rights>Copyright © 2014 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c423t-5385db5194612555acc5d303757f747687ff3f0a9f6c2f3ba4dce6dd79e7c2703</citedby><cites>FETCH-LOGICAL-c423t-5385db5194612555acc5d303757f747687ff3f0a9f6c2f3ba4dce6dd79e7c2703</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.thromres.2014.08.018$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25213709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kotzé, Retha C.M</creatorcontrib><creatorcontrib>Ariëns, Robert A.S</creatorcontrib><creatorcontrib>de Lange, Zelda</creatorcontrib><creatorcontrib>Pieters, Marlien</creatorcontrib><title>CVD risk factors are related to plasma fibrin clot properties independent of total and or γ’ fibrinogen concentration</title><title>Thrombosis research</title><addtitle>Thromb Res</addtitle><description>Abstract Introduction Cardiovascular disease (CVD) risk factors are associated with total fibrinogen concentration and/or altered clot structure. It is however, unclear whether such associations with clot structure are ascribed to fibrinogen concentration or other independent mechanisms. We aimed to determine whether CVD risk factors associated with increased total and/or γ’ fibrinogen concentration, were also associated with altered fibrin clot properties and secondly whether such associations were due to the fibrinogen concentration or through independent associations. Materials and methods In a plasma setting CVD risk factors (including total and γ’ fibrinogen concentration) were cross-sectionally analysed in 2010 apparently healthy black South African participants. Kinetics of clot formation (lag time, slope and maximum absorbance) as well as clot lysis times were calculated from turbidity curves. Results Of the measured CVD risk factors age, metabolic syndrome, C-reactive protein (CRP), high density lipoprotein (HDL)-cholesterol and homocysteine were significantly associated with altered fibrin clot properties after adjustment for total and or γ’ fibrinogen concentration. Aging was associated with thicker fibres (p = 0.004) while both metabolic syndrome and low HDL-cholesterol levels were associated with lower rates of lateral aggregation (slope), (p = 0.0004 and p = 0.0009), and the formation of thinner fibres (p = 0.007 and p = 0.0004). Elevated CRP was associated with increased rates of lateral aggregation (p = 0.002) and consequently thicker fibres (p < 0.0001). Hyperhomocysteinemia was associated with increased rates of lateral aggregation (p = 0.0007) without affecting fibre thickness. Conclusion Final clot structure may contribute to increased CVD risk in vivo through associations with other CVD risk factors independent from total or γ’ fibrinogen concentration.</description><subject>Adult</subject><subject>Blood Coagulation</subject><subject>Cardiovascular Diseases - blood</subject><subject>Cardiovascular Diseases - etiology</subject><subject>Cardiovascular Diseases - metabolism</subject><subject>CVD risk factors</subject><subject>Female</subject><subject>Fibrin - analysis</subject><subject>Fibrin - metabolism</subject><subject>Fibrin Clot Lysis Time</subject><subject>Fibrin clot structure</subject><subject>Fibrinogen</subject><subject>Fibrinogens, Abnormal - analysis</subject><subject>Fibrinolysis</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Plasma</subject><subject>Risk Factors</subject><issn>0049-3848</issn><issn>1879-2472</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkTuOFDEQhi0EYoeFK6wckkzjZ7udINDwlFYi4CEyy2OXwbPd7cb2IDbjGpyDe3AIToJHM0tAQmI7-P6q8lcIXVDSUUL7R7uufs5pylA6RqjoyNAROtxCKzoovWZCsdtoRYjQaz6I4QzdK2VHCFVUy7vojElGuSJ6hb5tPjzDOZYrHKyrKRdsM-AMo63gcU14GW2ZLA5xm-OM3ZgqXnJaINcIBcfZwwLtmCtOofHVjtjOHqeMf_38_f3HKZg-QQun2TUw2xrTfB_dCXYs8OB0n6P3L56_27xaX755-Xrz9HLtBON1Lfkg_VZSLXrKpJTWOek54UqqoITqBxUCD8Tq0DsW-NYK76D3XmlQjinCz9HDY9029Zc9lGqmWByMo50h7YuhPdO614PuG9ofUZdTKRmCWXKcbL42lJiDdbMzN9bNwbohg2nWW_Di1GO_ncD_jd1obsCTIwDtp18jZFNchGbDxwyuGp_i_3s8_qeEG-McnR2v4BrKLu3z3DwaagozxLw97P6weiraS4qP_A9o-K91</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Kotzé, Retha C.M</creator><creator>Ariëns, Robert A.S</creator><creator>de Lange, Zelda</creator><creator>Pieters, Marlien</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20141101</creationdate><title>CVD risk factors are related to plasma fibrin clot properties independent of total and or γ’ fibrinogen concentration</title><author>Kotzé, Retha C.M ; Ariëns, Robert A.S ; de Lange, Zelda ; Pieters, Marlien</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c423t-5385db5194612555acc5d303757f747687ff3f0a9f6c2f3ba4dce6dd79e7c2703</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Blood Coagulation</topic><topic>Cardiovascular Diseases - blood</topic><topic>Cardiovascular Diseases - etiology</topic><topic>Cardiovascular Diseases - metabolism</topic><topic>CVD risk factors</topic><topic>Female</topic><topic>Fibrin - analysis</topic><topic>Fibrin - metabolism</topic><topic>Fibrin Clot Lysis Time</topic><topic>Fibrin clot structure</topic><topic>Fibrinogen</topic><topic>Fibrinogens, Abnormal - analysis</topic><topic>Fibrinolysis</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Plasma</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kotzé, Retha C.M</creatorcontrib><creatorcontrib>Ariëns, Robert A.S</creatorcontrib><creatorcontrib>de Lange, Zelda</creatorcontrib><creatorcontrib>Pieters, Marlien</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Thrombosis research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kotzé, Retha C.M</au><au>Ariëns, Robert A.S</au><au>de Lange, Zelda</au><au>Pieters, Marlien</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CVD risk factors are related to plasma fibrin clot properties independent of total and or γ’ fibrinogen concentration</atitle><jtitle>Thrombosis research</jtitle><addtitle>Thromb Res</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>134</volume><issue>5</issue><spage>963</spage><epage>969</epage><pages>963-969</pages><issn>0049-3848</issn><eissn>1879-2472</eissn><abstract>Abstract Introduction Cardiovascular disease (CVD) risk factors are associated with total fibrinogen concentration and/or altered clot structure. It is however, unclear whether such associations with clot structure are ascribed to fibrinogen concentration or other independent mechanisms. We aimed to determine whether CVD risk factors associated with increased total and/or γ’ fibrinogen concentration, were also associated with altered fibrin clot properties and secondly whether such associations were due to the fibrinogen concentration or through independent associations. Materials and methods In a plasma setting CVD risk factors (including total and γ’ fibrinogen concentration) were cross-sectionally analysed in 2010 apparently healthy black South African participants. Kinetics of clot formation (lag time, slope and maximum absorbance) as well as clot lysis times were calculated from turbidity curves. Results Of the measured CVD risk factors age, metabolic syndrome, C-reactive protein (CRP), high density lipoprotein (HDL)-cholesterol and homocysteine were significantly associated with altered fibrin clot properties after adjustment for total and or γ’ fibrinogen concentration. Aging was associated with thicker fibres (p = 0.004) while both metabolic syndrome and low HDL-cholesterol levels were associated with lower rates of lateral aggregation (slope), (p = 0.0004 and p = 0.0009), and the formation of thinner fibres (p = 0.007 and p = 0.0004). Elevated CRP was associated with increased rates of lateral aggregation (p = 0.002) and consequently thicker fibres (p < 0.0001). Hyperhomocysteinemia was associated with increased rates of lateral aggregation (p = 0.0007) without affecting fibre thickness. Conclusion Final clot structure may contribute to increased CVD risk in vivo through associations with other CVD risk factors independent from total or γ’ fibrinogen concentration.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>25213709</pmid><doi>10.1016/j.thromres.2014.08.018</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0049-3848 |
ispartof | Thrombosis research, 2014-11, Vol.134 (5), p.963-969 |
issn | 0049-3848 1879-2472 |
language | eng |
recordid | cdi_proquest_miscellaneous_1629969896 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Adult Blood Coagulation Cardiovascular Diseases - blood Cardiovascular Diseases - etiology Cardiovascular Diseases - metabolism CVD risk factors Female Fibrin - analysis Fibrin - metabolism Fibrin Clot Lysis Time Fibrin clot structure Fibrinogen Fibrinogens, Abnormal - analysis Fibrinolysis Hematology, Oncology and Palliative Medicine Humans Male Middle Aged Plasma Risk Factors |
title | CVD risk factors are related to plasma fibrin clot properties independent of total and or γ’ fibrinogen concentration |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T12%3A37%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CVD%20risk%20factors%20are%20related%20to%20plasma%20fibrin%20clot%20properties%20independent%20of%20total%20and%20or%20%CE%B3%E2%80%99%20fibrinogen%20concentration&rft.jtitle=Thrombosis%20research&rft.au=Kotz%C3%A9,%20Retha%20C.M&rft.date=2014-11-01&rft.volume=134&rft.issue=5&rft.spage=963&rft.epage=969&rft.pages=963-969&rft.issn=0049-3848&rft.eissn=1879-2472&rft_id=info:doi/10.1016/j.thromres.2014.08.018&rft_dat=%3Cproquest_cross%3E1629969896%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1629969896&rft_id=info:pmid/25213709&rft_els_id=1_s2_0_S004938481400454X&rfr_iscdi=true |